Form 4: Ardent Health Partners Director Peter C B Bynoe Acquires Shares Through Restricted Stock Units

Director Peter C B Bynoe of Ardent Health Partners acquired 10,793 shares of common stock through restricted stock units on December 12, 2024.

Summary

• Peter C B Bynoe, a director at Ardent Health Partners, acquired 10,793 shares of common stock on December 12, 2024.
• The acquisition was through restricted stock units (RSUs).
• These RSUs will vest in three equal installments on the first, second, and third anniversaries of December 12, 2024.
• The vesting is subject to pro-rata vesting if Bynoe's service as a director terminates under certain circumstances related to the company's annual meeting of stockholders.
• Following this transaction, Bynoe now beneficially owns 88,220 shares of Ardent Health Partners common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard transaction of a director acquiring shares, indicating alignment with shareholder interests.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.

Risks

• The vesting of the restricted stock units is contingent on Bynoe's continued service as a director, which could be impacted by various factors.

Future Outlook

The restricted stock units will vest over the next three years, subject to the director's continued service.

Industry Context

This is a standard transaction for directors of publicly traded companies, often used as part of their compensation and to align their interests with shareholders.

Comparison to Industry Standards

• The use of restricted stock units as part of director compensation is a common practice across the healthcare industry.
• Many companies, such as HCA Healthcare and Tenet Healthcare, also use similar equity-based compensation for their directors.
• The vesting schedule of three years is also typical for these types of grants.

Stakeholder Impact

• The transaction aligns the director's interests with those of shareholders, as the value of the shares is tied to the company's performance.

Next Steps

• The restricted stock units will continue to vest annually over the next three years.

Key Dates

Keywords

Ardent Health Partners, Director, Peter C B Bynoe, Restricted Stock Units, RSU, Share Acquisition, Beneficial Ownership, Stock Vesting